| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net cash provided by financing activities | 3,046 | 3,108 |
| Effect of foreign currency translation on cash | 48 | 51 |
| Net decrease in cash and cash equivalents | -14,918 | -8,257 |
| Cash and cash equivalents at beginning of period | 21,338 | - |
| Cash and cash equivalents at end of period | 6,420 | - |
Traws Pharma, Inc. (TRAW)
Traws Pharma, Inc. (TRAW)